Petros Pharmaceuticals, Inc.
PTPI
Revenue
1.42M
▲32.67k▲2.35%
3 Months ChangeAssets
25.17M
▼-5.14M▼-16.97%
3 Months ChangeLiabilities
15.98M
▼-3.64M▼-18.53%
3 Months ChangeFree Cash Flow
-2.38M
▼-2.38M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-18
Form 8-K
ID: 0001104659-24-109893
2024-10-17
Form 8-K
ID: 0001104659-24-109575
2024-10-04
Form 8-K
ID: 0001104659-24-106322
2024-09-19
Form 8-K
ID: 0001104659-24-101333
2024-08-14
Form 10-Q
ID: 0001410578-24-001437
2024-05-15
Form 10-Q
ID: 0001410578-24-000885
2024-03-22
Form 8-K
ID: 0001104659-24-037906
2024-01-12
Form 8-K
ID: 0001104659-24-003706
2023-12-29
Form 8-K
ID: 0001104659-23-130468
2023-12-28
Form 8-K
ID: 0001104659-23-130046